TDX Tyrian Fpo

Tyrian Diagnostics Limited (ASX:TDX) announced today that the Company has agreed to commence the development of a second point-of-need diagnostic product with Bayer CropScience AG (�Bayer�). The product will utilise Tyrian Diagnostics� (�Tyrian�) DiagnostIQ� test device and the test content will be provided by Bayer. This new project follows the commencement of marketing by Bayer of the first product generated by the collaboration, WheatRite�, a test for analysis of wheat quality. Jenny Harry, CEO of Tyrian Diagnostics, said �We are delighted that Bayer has committed to development of a second innovative application for our DiagnostIQ platform and we continue to pursue advancement of this technology in other product areas." Tyrian expects to complete the proof-of-concept phase of this product development programme by 2nd quarter 2009. Bayer will fund the development costs of the project and Tyrian would receive annual�licence fees and royalties on net sales of a commercial product. About DiagnostIQ� DiagnostIQ� is a point-of-need diagnostic test platform for the development of rapid and quantitative tests. The patented technology comprises an antibody/antigen printed membrane, a unique pre-filter device and an incubation chamber in a vertical flow-through format. The test is simple to use, gives rapid and accurate results, and is suitable for use with crude samples such as whole blood, sputum, saliva, or plant materials. The DiagnostIQ test can be used with a portable digital reader when quantitative test results are required. DiagnostIQ has the potential to be used as a diagnostic platform for virtually any analyte for which antibodies or antigens are available. The global market opportunity for such tests is very large and the discovery of new high quality disease biomarkers is expected to fuel further growth. About Tyrian Diagnostics Tyrian Diagnostics (ASX:TDX) is a diagnostics company with expertise in biomarker discovery and validation and diagnostic test development and a core focus on respiratory and infectious diseases. In addition, Tyrian can partner in alternative fields given its capabilities to work across the entire spectrum of diagnostic test development � from identification and isolation of biomarkers, point-of-need test design, clinical development or field testing to final product. Tyrian�s product pipeline includes: WheatRite� for measuring wheat quality, which is partnered with Bayer CropScience AG; and a rapid test for active tuberculosis, in collaboration with US-based diagnostic group Becton, Dickinson and Company. Additional information about Tyrian Diagnostics can be found at www.tyriandx.com